In life, as well as in business, making a decision with a gun to your head rarely yields good results. Unless, of course, you maintain your cool, says Morrison & Foerster partner David Doyle.

That’s exactly how his client, San Diego-based Acon Laboratories, a tiny biotechnology company, avoided a three-year bet-the-company patent infringement suit — by instead sealing a $175 million deal announced Feb. 24.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]